(Total Views: 231)
Posted On: 11/07/2022 10:00:50 AM
Post# of 44

$AFMD News Article - Affimed Provides Data Update from Two Phase 1/2a Trials with its Innate Cell Engager AFM24 in Solid Tumor Patients at the 37th SITC Annual Meeting https://marketwirenews.com/news-releases/affi...56447.html


My Twitter: WhyteStocks